greeksoup/ stock research
Stock research / United States / CC / FY2013

Chemours (CC) FY2013 results: revenue $6.9 billion

Chemours Co. (CC) reported revenue of $6.9 billion for fiscal 2013, the year ended 31 December 2013. Net income was $423 million, and diluted earnings per share $2.34. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2016.

Revenue
$6.9 billion
FY2013FY2013
Operating margin
86.4%
FY2013FY2013
Net income
$423 million
FY2013FY2013
Diluted EPS
$2.34
FY2013FY2013

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2013Last 8 years
Revenue6,859
Cost of revenue5,395
Gross profit1,464
Gross margin21.3%
Research and development164
Selling, general and administrative768
Operating income5,925
Operating margin86.4%
Interest expense0.0
Pre-tax income576
Income tax152
Effective tax rate26.4%
Net income423
Net margin6.2%
Diluted EPS$2.34
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2013Last 8 years
Operating cash flow798
Capital expenditure438
Free cash flow360
Free cash flow margin5.2%
Cash from investing-424
Cash from financing-374
Depreciation and amortisation261
Share-based compensation6.0
Dividends paid0.0
Diluted shares, weighted181m

Balance sheet

$ millionFY2013Last 8 years
Shareholders' equity3,217
Fixed assets2,972
Goodwill198
Cash and equivalents0.0

10-K for the year ended 31 December 2013, filed 25 February 2016: the filing.